Mark P. Robinson, Jr. and Daniel S. Robinson Named to Daily Journal’s List of Top 25 Plaintiff Lawyers in California for 2015

Mark P. Robinson, Jr. and Daniel S. Robinson Named Daily Journal's Top 25 Plaintiffs Lawyers for 2015

July 16, 2015 – Founding and senior partner Mark P. Robinson, Jr. and partner Daniel S. Robinson were recently named to the Daily Journal’s inaugural list of Top 25 Plaintiff Lawyers in California for 2015. Established in 1893, the Daily Journal is known as one of the foremost legal publications in the U.S. This reputable publication is widely respected by California attorneys in all practice areas for its extensive coverage and profiles of judges, appellate decisions, and other notable legal information.

According to the Daily Journal, the attorneys are being honored for “truly caring about having an impact” on state and federal policy changes that benefit society. Mark and Daniel Robinson were recognized for the significant impact they have made in the areas of consumer safety and products liability.

Mark P. Robinson, Jr. 

Mark P. Robinson, Jr. Full article:  Mark Robinson Named as Top 25 Lawyer

Mark was recognized for his outstanding achievements in some of the country’s most complex and notable litigation against large auto manufacturers and pharmaceutical companies. His achievements include serving as lead attorney in the landmark Ford Pinto exploding gas tank case, Grimshaw v. Ford Motor Company, which resulted in a $128 verdict for his client; a historic $4.9 billion personal jury verdict in the fiery burn case Anderson v. General Motors; and a $51 million verdict in the only successful federal court trial in the national Vioxx litigation, Barnett v. Merck.

Mark was appointed by the U.S. District Judge James V. Selna to serve as co-lead counsel for the In Re: Toyota Motor Corp. Unintended Acceleration Mktg., Sales Prac. & Prods. Liab. Litig. Cases, which resulted in a record-setting class action settlement. Mark’s continued success lead to his more recent appointment to serve on the Executive Committee for the In Re: General Motors LLC Ignition Switch LitigationHe is also serving as Plaintiffs’ Co-Lead and on the Plaintiff’s Executive Committee, In Re: Zoloft Products Liability Litigation, MDL 2342 12-MD-2342, and on the Plaintiffs’ Executive Committee, In Re: Actos Product Liability Cases, MDL 6:11-md-2299.

“My primary goal is representing clients and getting fair compensation for them,” said Mark in the Daily Journal feature. “But I found out that sometimes there is a significant, collateral, societal benefit.”

Daniel S. Robinson

DSR-Profile-NaturalFull article: Daniel Robinson Named as Top 25 Lawyer

Daniel was recognized for holding influential leadership roles in the areas of catastrophic personal injury, medical product liability, and class actions litigation. He has secured a number of multimillion-dollar settlements for clients, including more than $100 million for injuries related to an alleged defective birth control product. He has also successfully handled several individual cases, including a $14.5 million verdict for a man paralyzed in a motorcycle accident, a $4.2 million settlement in a premises liability case, a $1.8 million settlement in a negligent security case, and a $1.2 million settlement in an elevator product defect case, among others.

Dan currently holds several leadership roles in class actions and mass tort matters, including Co-Lead Counsel, In Re: Risperdal and Invega Product Liability Cases, JCCP 4775, and St. Joseph Health System Medical Information CasesJCCP 4716; Plaintiffs’ Steering Committee, In Re: Actos (Pioglitazone) Products Liability Litigation, JCCP 4696, and In Re: Fosamax/Alendronate Sodium Drug Cases, JCCP 4644;  Plaintiffs’ Executive Committee, In Re: Biomet M2a Magnum Hip Implant Products Liability Litigation, MDL 2391, and Heparin Products Liability Litigation, MDL 1953.

“This is a pivotal case,” said Daniel to the Daily Journal regarding St. Joseph Health System Medical Information Cases. He added that this is the type of breach California’s confidentiality of Medical Information Act (CMIA) was intended to remedy.